Emma Walmsley to head up GSK consumer healthcare

pharmafile | March 23, 2010 | Appointment | Sales and Marketing GlaxoSmithKline, appointment, consumer healthcare, sales and marketing 

GlaxoSmithKline has appointed Emma Walmsley president, Consumer Healthcare Europe and president designate, Worldwide Consumer Healthcare with effect from 1 May.

She joins GSK from L’Oreal where she led their consumer products business in China.

Prior to this Emma was based in New York where she had global responsibility for the mass-market Maybelline cosmetics business.

As president, Consumer Healthcare Europe, Emma will have operational responsibility for GSK’s European business and brands, succeeding Manfred Scheske, and will assume global leadership for the Consumer Healthcare business within two years from John Clarke.

GSK chief executive Andrew Witty said: “Under John’s leadership, Consumer Healthcare has become a key element in GSK’s strategy to deliver sustainable financial performance.

“Emma’s appointment comes at an important time as we seek to diversify and further grow this business. It is also continued evidence of our approach to maintain leadership excellence at GSK through proactive succession planning.”

Related Content

GSK building

GSK and Vir Biotechnology COVID-19 drug found to reduce deaths and hospitalisation by 85%

Vir Biotechnology and GSK have announced that their monoclonal-antibody drug has been found to reduce …

GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine

GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new …

NICE recommends GSK’s ZEJULA for advanced ovarian cancer

NICE has recommended the use of GlaxoSmithKline’s ZEJULA (niraparib) on the NHS in England for …

Latest content